Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

BRITISH JOURNAL OF HAEMATOLOGY

WILEY-BLACKWELL

1. Medical Research Council [MR/L006340/1, MC_UU_12009/16] Funding Source: Medline
2. MRC [MC_UU_12009/16, MR/L006340/1] Funding Source: UKRI
3. Medical Research Council [MC_UU_12009/16, MR/L006340/1] Funding Source: researchfish
4. Public Health Agency [EAT/3717/07] Funding Source: researchfish